New cancer drug trial seeks to control advanced tumors
NCT ID NCT04009681
Summary
This study tested a new drug called THOR-707, both by itself and combined with other cancer therapies, in adults with advanced or spreading solid tumors. The main goals were to find safe and effective doses and to see if the treatment could shrink tumors. The trial has been terminated and enrolled 175 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number- 6001
Santiago, Chile
-
Investigational Site Number-1001
San Antonio, Texas, 78229, United States
-
Investigational Site Number-1002
Houston, Texas, 77030, United States
-
Investigational Site Number-1003
Nashville, Tennessee, 37203, United States
-
Investigational Site Number-1004
Sarasota, Florida, 34232, United States
-
Investigational Site Number-1005
Denver, Colorado, 80218, United States
-
Investigational Site Number-1007
Dallas, Texas, 75032, United States
-
Investigational Site Number-1008
Scottsdale, Arizona, 85250, United States
-
Investigational Site Number-2001
Perth, Australia
-
Investigational Site Number-2002
Victoria, Australia
-
Investigational Site Number-2003
Victoria, Australia
-
Investigational Site Number-2004
New South Whales, Australia
-
Investigational Site Number-4002
Singapore, Singapore
-
Investigational Site Number-5001
Barcelona, Spain
-
Investigational Site Number-5002
Madrid, Spain
-
Investigational Site Number-5003
Madrid, Spain
-
Investigational Site Number-5004
Madrid, Spain
-
Investigational Site Number-5005
Madrid, Spain
-
Investigational Site Number-5006
Barcelona, Spain
-
Investigational Site Number-5007
Barcelona, Spain
-
Investigational Site Number-5105
Madrid, Spain
-
Investigational Site Number-6002
Santiago, Chile
-
Investigational Site Number-7002
Buenos Aires, Argentina
-
Investigational Site-4001
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.